Summary
2.77 0.32(13.06%)11/01/2024
Aerovate Therapeutics Inc (AVTE)
Aerovate Therapeutics Inc (AVTE)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
11.02 | 31.28 | 33.82 | 53.89 | -86.57 | -73.97 | 0.00 | -87.87 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 2.77 | |
Open | 2.49 | |
High | 2.80 | |
Low | 2.49 | |
Volume | 2,684,324 | |
Change | 0.28 | |
Change % | 11.02 | |
Avg Volume (20 Days) | 2,434,898 | |
Volume/Avg Volume (20 Days) Ratio | 1.10 | |
52 Week Range | 1.25 - 32.16 | |
Price vs 52 Week High | -91.39% | |
Price vs 52 Week Low | 121.60% | |
Range | 11.24 | |
Gap Up/Down | -0.51 |
Fundamentals | ||
Market Capitalization (Mln) | 60 | |
EBIDTA | 0 | |
PE Ratio | 0.0000 | |
PEG Ratio | 0.0000 | |
WallStreet Target Price | 0.00 | |
Book Value | 0.0000 | |
Earnings Per Share | 0.0000 | |
EPS Estimate Current Quarter | 0.0000 | |
EPS Estimate Next Quarter | 0.0000 | |
EPS Estimate Current Year | 0.0000 | |
EPS Estimate Next Year | 0.0000 | |
Diluted EPS (TTM) | 0.0000 | |
Revenues | ||
Profit Marging | 0.0000 | |
Operating Marging (TTM) | 0.0000 | |
Return on asset (TTM) | 0.0000 | |
Return on equity (TTM) | 0.0000 | |
Revenue TTM | 0 | |
Revenue per share TTM | 0.0000 | |
Quarterly Revenue Growth (YOY) | 0.0000 | |
Quarterly Earnings Growth (YOY) | 0.0000 | |
Gross Profit (TTM) | 0 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 0.0000 | |
Forward PE | 0.0000 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 0.0000 | |
Revenue Enterprise Value | 0.0000 | |
EBITDA Enterprise Value | 0.0000 | |
Shares | ||
Shares Outstanding | 0 | |
Shares Float | 0 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 0.00 | |
Institutions (%) | 0.00 |